Profile
Dayan Colin is currently the Chair of Clinical Diabetes and Metabolism and Head at the University of Cardiff, as well as a Partner and Advisor at JDRF T1D Fund.
Previously, he was the Director at the Institute of Molecular Immunology.
Mr. Colin received a doctorate degree from University College Oxford.
Dayan Colin active positions
| Companies | Position | Start |
|---|---|---|
JDRF T1D Fund
 JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Consultant / Advisor | - |
| University of Cardiff | Chairman | - |
Former positions of Dayan Colin
| Companies | Position | End |
|---|---|---|
| Institute of Molecular Immunology | Director/Board Member | - |
Training of Dayan Colin
| University College Oxford | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
| Institute of Molecular Immunology | |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts. | Finance |
- Stock Market
- Insiders
- Dayan Colin
